PGL Share Price

Open 0.22 Change Price %
High 0.22 1 Day 0.00 0.00
Low 0.20 1 Week 0.00 0.00
Close 0.22 1 Month 0.00 0.00
Volume 68707 1 Year 0.00 0.00
52 Week High 0.94
52 Week Low 0.53
PGL Important Levels
Resistance 2 0.24
Resistance 1 0.23
Pivot 0.21
Support 1 0.21
Support 2 0.20
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
AKK 0.01 0.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
OMH 0.18 28.57%
SRZ 0.05 25.00%
SRZ 0.05 25.00%
HGO 0.05 25.00%
HGO 0.05 25.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
GBA 0.02 -33.33%
DAU 0.02 -33.33%
More..

Progen Pharmaceuticals Ltd (ASX: PGL)

PGL Technical Analysis 2.5
As on 4th Dec 2015 PGL Share Price closed @ 0.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.23 & Strong Buy for SHORT-TERM with Stoploss of 0.19 we also expect STOCK to react on Following IMPORTANT LEVELS.
PGL Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
PGL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.progen-pharma.com
PGL Address
PGL
2806 Ipswich Road
Darra, QLD 4076
Australia
Phone: 61 7 3273 9133
Fax: 61 7 3375 1168
PGL Latest News
Week In Review: Week's China Life Science Deals Total $795 Million   Seeking Alpha   - 20th Nov 16
TBG Diagnostics Limited to File Form 15-F to Voluntarily Terminate SEC ...   Business Wire (press release)   - 05th Aug 16
TBG Diagnostics Ltd to generate higher sales on Taiwanese acquisition   Proactive Investors Australia   - 29th Jun 16
Indonesia's Tower Bersama looks to raise up to $500m from note programme   DEALSTREETASIA   - 04th Apr 16
Victorian Government sets up expert panel to boost innovation   Delimiter   - 15th Feb 16
Progen Pharma changes name to TBG Diagnostics   Seeking Alpha   - 14th Dec 15
Progen Pharmaceuticals in ASX trading halt   Proactive Investors Australia   - 07th Dec 15
Auctions hold ground   Finance News Network   - 30th Nov 15
Progen Pharmaceuticals buys molecular diagnostics firm TBG from Medigen   Seeking Alpha   - 19th Oct 15
TB control programme to engage private sector   The Hindu   - 20th Sep 12
Interactive Technical Analysis Chart Progen Pharmaceuticals Ltd ( PGL ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Progen Pharmaceuticals Ltd
PGL Business Profile
Progen Pharmaceuticals Limited, a biotechnology company, discovers, researches, and develops biopharmaceutical therapeutics for the treatment of human diseases in Australia and the United States. It focuses on the development of the anti-angiogenesis and anti-metastatic oncology products pipeline. The company’s products in research and development stage include PG545, an anti-cancer compound in preclinical development; and PI-88 melanoma program that is in Phase 2 clinical development stage. It also provides contract services related to the process development, manufacture, and quality assurance of biological products. The company, formerly known as Progen Industried Limited, was incorporated in 1989 and is based in Darra, Australia.